Skip to content

Cranberry for the Prevention of Urinary Tract Infections

The Beneficial Effects of a Cranberry-based Oral Nutritional Supplement on the Prevention of Urinary Tract Infections in Diabetic Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05730998
Enrollment
60
Registered
2023-02-16
Start date
2022-09-01
Completion date
2023-01-31
Last updated
2023-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Urinary Infection

Brief summary

This research aims to evaluate the potential benefit of an oral nutritional supplement based on Anthocran phytosome compared to placebo on the prevention of urinary infections, including microbiota analyzes, in postmenopausal women (\> 70 years) with diabetes. For each subject enrolled, all parameters relating to urinary infections will be assessed at the beginning (baseline), every 2 months from the start of treatment and at the end of treatment (6 months), with urine analysis and quality of life questionnaires.

Interventions

DIETARY_SUPPLEMENTANTHOCRAN FITOSOMA

The product (Anthocran phytosome or placebo) will be taken in the quantity of 1 capsule of 120 mg, 1 times a day, for 6 months

DIETARY_SUPPLEMENTPLACEBO

Placebo will be taken in the quantity of 1 capsule of 120 mg, 1 times a day, for 6 months

Sponsors

Azienda di Servizi alla Persona di Pavia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* postmenopausal women (\> 70 years) with diabetes. * treatment with SGLT-2 inhibitors * disease duration for at least 10 years, with at least 1 episode of infection the previous year and Charlson's co-morbidity index\> 6.

Design outcomes

Primary

MeasureTime frameDescription
urinalysisAt baselineUrinalysis included color, specific gravity, pH, glucose, protein, red blood cell, white blood cell. Microscopic examinations were performed under a clinical light microscope (Olympus Opto Systems India Pvt. Ltd. New Delhi, India).

Secondary

MeasureTime frameDescription
urine cultureAt baselineA positive urinary culture was defined as growth of a single urine pathogen of \>104 cfu/mL urine specimen.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026